14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Aug 25, 2026
OSRH vs ABVE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Aug 25, 2026, Above Food Ingredients Inc. (ABVE) is the stronger overall head-to-head candidate over OSR Holdings, Inc. (OSRH) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). OSRH carries a Unified Composite Score of 45.0/100 (HOLD) at $0.12 (N/M Forward P/E, -960.8% operating margin), whereas ABVE carries 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin).
Composite vs. Pillar Nuance: While OSRH currently prints a higher short-term Unified Composite Score (45.0/100 HOLD vs. ABVE 39.8/100 SELL), ABVE captures the overall institutional head-to-head verdict (5–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-23.2% vs. -960.8% operating margin) and revenue trajectory (-45.0% vs. -72.2% YoY).
Technical & Structure Timing Caution: OSRH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.4); meanwhile ABVE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OSRH vs ABVE. Trailing 12-month operating profitability (OSRH -960.8% vs ABVE -23.2%) and valuation multiples (OSRH N/M vs ABVE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Packaged Foods value chain with $30.0M market capitalization and -23.2% operating margin.
OpEx & R&D Reinvestment20.4% of Rev ($60M)
90D Engineering Disclosures0 Published
Investor FAQ OSRH vs ABVE Key Questions & Quantitative Answers
As of Aug 25, 2026, Above Food Ingredients Inc. (ABVE) is the stronger overall head-to-head candidate over OSR Holdings, Inc. (OSRH) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). OSRH carries a Unified Composite Score of 45.0/100 (HOLD) at $0.12 (N/M Forward P/E, -960.8% operating margin), whereas ABVE carries 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin). Composite vs. Pillar Nuance: While OSRH currently prints a higher short-term Unified Composite Score (45.0/100 HOLD vs. ABVE 39.8/100 SELL), ABVE captures the overall institutional head-to-head verdict (5–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-23.2% vs. -960.8% operating margin) and revenue trajectory (-45.0% vs. -72.2% YoY). Technical & Structure Timing Caution: OSRH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.4); meanwhile ABVE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ABVE leads the Growth & Scale pillar: OSRH posts -72.2% YoY revenue growth and +0.0% YoY earnings growth on $1.8M TTM revenue (33.4% gross margin, -960.8% operating margin), compared with ABVE at -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin). On trailing 12-month operating scale, OSRH generates $1.8M in USD-normalized revenue versus $295M for ABVE. In operating R&D and SG&A reinvestment, OSRH deploys N/A (0 90-day corporate R&D disclosures) versus 20.4% of Rev ($60M) (0 disclosures) for ABVE.
ABVE screens cheaper on headline valuation multiples. OSRH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 6.7x EV/Revenue (unreported FCF margin), whereas ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OSRH (-11.3% ROE) versus ABVE (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, OSRH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.57β · 390% Vol realized risk). By comparison, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Aug 25, 2026. For educational research only; not investment advice.